Top Biotechnology & Medical Research stocks in Canada

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Market Cap
Price to Earnings
Dividend Yield
ca flag iconBLUBELLUS HealthCA$2.47bnn/an/a
ca flag iconNGENNervgen PharmaCA$214.83mn/an/a
ca flag iconCRDLCardiol TherapeuticsCA$200.10mn/an/a
ca flag iconMDNAMedicenna TherapeuticsCA$164.16mn/an/a
ca flag iconZENZentekCA$133.41mn/an/a
ca flag iconEPRXEupraxia PharmaceuticalsCA$131.80mn/an/a
ca flag iconACOGAlpha CognitionCA$114.38mn/an/a
ca flag iconONCOncolytics BiotechCA$109.89mn/an/a
ca flag iconARCHArch BiopartnersCA$104.08mn/an/a
ca flag iconMETXME Therapeutics HoldingsCA$100.76mn/an/a
ca flag iconMSETMindset pharmaCA$74.96mn/an/a
ca flag iconZYUSZyus Life SciencesCA$73.68mn/an/a
ca flag iconMSCLSatellos BioscienceCA$56.40mn/an/a
ca flag iconHBPHelix BiopharmaCA$56.37mn/an/a
ca flag iconKDAKDACA$52.65mn/an/a
ca flag iconCOVCovalon TechnologiesCA$50.57mn/an/a
ca flag iconAVCNAvicannaCA$47.34mn/an/a
ca flag iconMBXMicrobix BiosystemsCA$42.38m43.72n/a
ca flag iconNRXNurexone BiologicCA$42.31mn/an/a
ca flag iconDTCDefence TherapeuticsCA$40.07mn/an/a